Essential requirements of Eif4a3 in brain development and disease
Eif4a3 在大脑发育和疾病中的基本需求
基本信息
- 批准号:10646299
- 负责人:
- 金额:$ 34.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBindingBiological AssayBrainBrain PathologyCellsClustered Regularly Interspaced Short Palindromic RepeatsComplexCopy Number PolymorphismCorpus CallosumCoupledData SetDefectDevelopmentDiagnosticDiseaseEtiologyEukaryotic Initiation Factor-4AExhibitsExonsFundingGenesGeneticGenomicsGoalsGrantHumanImageImpairmentIn VitroIntellectual functioning disabilityMeasuresMediatingMicrocephalyMicrotubulesMitosisMolecularMusMutant Strains MiceMutateMutationNeurodevelopmental DisorderNeuronsNewborn InfantPathologyPatientsPhenotypePositioning AttributeProcessProliferatingRNARNA BindingRadialRegulationRoleSedimentation processSpecific qualifier valueSyndromeTestingTherapeuticTranscriptautism spectrum disordercognitive disabilitycraniofacialexcitatory neuronfetalgenetic analysisimaging modalityin vivoinduced pluripotent stem cellinsightmouse modelmutantnerve stem cellnervous system disorderneurodevelopmentneurogenesisneuron developmentneuroregulationnovelprogenitorstem cell modeltooltranscriptomeunpublished works
项目摘要
Abstract
Eif4a3 is a component of an RNA binding exon junction complex (EJC) implicated in neural development and
disease. The EJC is composed of Eif4a3, Magoh, and Rbm8a. EIF4A3 mutations are associated with intellectual
disability and hypomorphic mutations cause Richieri-Costa-Pereira syndrome (RCPS), a craniofacial
developmental syndrome accompanied by microcephaly and cognitive disability. Yet, the underlying
mechanisms of EIF4A3-mediated neurodevelopmental pathologies remain largely unknown. This renewal
proposal aims to address this gap by defining requirements for Eif4a3 in two critical processes of cortical
development: neurogenesis and neuronal maturation. In the prior funding period of this grant, we discovered that
Magoh mutant progenitors exhibit prolonged mitosis, which directly alters fates of newborn progeny. We
generated mouse models for all 3 core EJC components. Using these mice we discovered that EJC
haploinsufficiency in progenitors results in strikingly similar defects in neurogenesis, microcephaly, and
dysregulation of common transcripts. Our genetic and genomic discoveries indicate that Eif4a3 may control
neural progenitors and neurogenesis via the EJC. In contrast, our recent unpublished work indicate that, Eif4a3
may have EJC-independent functions in neurons. Further, we implicate microtubule regulation in these non-
canonical mechanisms. Based on our findings we hypothesize that Eif4a3 employs canonical RNA regulatory
and non-canonical microtubule mechanisms to differentially control progenitors and neurons during brain
development. This proposal will test this hypothesis by exploiting unique mouse models and human iPSC
models, as well as live imaging assays developed in our lab. We will: (1) define cellular and molecular
mechanisms by which Eif4a3 influences neurogenesis, (2) determine developmental and molecular
requirements of Eif4a3 in neuronal maturation, and (3) determine the cellular and molecular impact of EIF4A3
mutations in human cells. Successfully completed, we will have significantly advanced our understanding of how
Eif4a3 controls critical stages of cortical development, via both canonical and non-canonical mechanisms. We
anticipate the discoveries resulting from this proposal will be broadly impactful for understanding cortical
development and the etiology of neurodevelopmental disease.
抽象的
Eif4a3 是 RNA 结合外显子连接复合物 (EJC) 的一个组成部分,与神经发育和
疾病。 EJC 由 Eif4a3、Magoh 和 Rbm8a 组成。 EIF4A3突变与智力相关
残疾和低等位基因突变会导致 Richieri-Costa-Pereira 综合征 (RCPS),这是一种颅面部疾病
伴有小头畸形和认知障碍的发育综合征。然而,底层
EIF4A3 介导的神经发育病理机制仍然很大程度上未知。此次续订
该提案旨在通过在皮质的两个关键过程中定义 Eif4a3 的要求来解决这一差距
发育:神经发生和神经元成熟。在本次资助的前期资助期间,我们发现
Magoh 突变祖细胞表现出延长的有丝分裂,这直接改变新生后代的命运。我们
为所有 3 个核心 EJC 组件生成鼠标模型。使用这些小鼠我们发现 EJC
祖细胞中的单倍体不足会导致神经发生、小头畸形和
共同转录本的失调。我们的遗传和基因组发现表明 Eif4a3 可能控制
通过 EJC 进行神经祖细胞和神经发生。相比之下,我们最近未发表的工作表明,Eif4a3
神经元中可能具有独立于 EJC 的功能。此外,我们将微管调节与这些非
规范机制。根据我们的发现,我们假设 Eif4a3 采用规范的 RNA 调控
和非经典微管机制在大脑过程中差异控制祖细胞和神经元
发展。该提案将通过利用独特的小鼠模型和人类 iPSC 来测试这一假设
模型以及我们实验室开发的实时成像分析。我们将:(1)定义细胞和分子
Eif4a3 影响神经发生的机制,(2) 决定发育和分子
Eif4a3 在神经元成熟中的要求,以及 (3) 确定 EIF4A3 的细胞和分子影响
人类细胞的突变。如果成功完成,我们将显着提高我们对如何
Eif4a3 通过规范和非规范机制控制皮质发育的关键阶段。我们
预计该提案的发现将对理解皮质产生广泛影响
神经发育疾病的发育和病因学。
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The exon junction complex in neural development and neurodevelopmental disease.
神经发育和神经发育疾病中的外显子连接复合体。
- DOI:
- 发表时间:2016-12
- 期刊:
- 影响因子:0
- 作者:McMahon, J J;Miller, E E;Silver, D L
- 通讯作者:Silver, D L
Adaptive sequence divergence forged new neurodevelopmental enhancers in humans.
适应性序列分歧在人类中形成了新的神经发育增强剂。
- DOI:
- 发表时间:2022-11-23
- 期刊:
- 影响因子:64.5
- 作者:Mangan, Riley J;Alsina, Fernando C;Mosti, Federica;Sotelo;Snellings, Daniel A;Au, Eric H;Carvalho, Juliana;Sathyan, Laya;Johnson, Graham D;Reddy, Timothy E;Silver, Debra L;Lowe, Craig B
- 通讯作者:Lowe, Craig B
Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
DDX3X 综合征模型中的异常皮质发育是由受损的细胞周期和翻译控制驱动的。
- DOI:
- 发表时间:2022-06-28
- 期刊:
- 影响因子:7.7
- 作者:Hoye, Mariah L;Calviello, Lorenzo;Poff, Abigail J;Ejimogu, Nna;Newman, Carly R;Montgomery, Maya D;Ou, Jianhong;Floor, Stephen N;Silver, Debra L
- 通讯作者:Silver, Debra L
Non-muscle myosins control radial glial basal endfeet to mediate interneuron organization.
非肌肉肌球蛋白控制放射状胶质细胞基端足以介导中间神经元组织。
- DOI:
- 发表时间:2023-02
- 期刊:
- 影响因子:9.8
- 作者:D'Arcy, Brooke R;Lennox, Ashley L;Manso Musso, Camila;Bracher, Annalise;Escobar;Perez;Silver, Debra L
- 通讯作者:Silver, Debra L
RNA on the brain: emerging layers of post-transcriptional regulation in cerebral cortex development.
大脑中的RNA:大脑皮层发育中转录后调控的新层。
- DOI:
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Lennox, Ashley L;Mao, Hanqian;Silver, Debra L
- 通讯作者:Silver, Debra L
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Debra Silver其他文献
Debra Silver的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Debra Silver', 18)}}的其他基金
Roles for uniquely human enhancers in brain development and WNT signaling
人类独特的增强子在大脑发育和 WNT 信号传导中的作用
- 批准号:
10577092 - 财政年份:2023
- 资助金额:
$ 34.5万 - 项目类别:
Dynamic control of cortical development and disease by mRNA stability
通过 mRNA 稳定性动态控制皮质发育和疾病
- 批准号:
10510361 - 财政年份:2022
- 资助金额:
$ 34.5万 - 项目类别:
Cell biological and proteomic investigation of pathogenic DDX3X missense mutations during neurogenesis
神经发生过程中致病性 DDX3X 错义突变的细胞生物学和蛋白质组学研究
- 批准号:
10313796 - 财政年份:2021
- 资助金额:
$ 34.5万 - 项目类别:
Cell biological and proteomic investigation of pathogenic DDX3X missense mutations during neurogenesis
神经发生过程中致病性 DDX3X 错义突变的细胞生物学和蛋白质组学研究
- 批准号:
10474429 - 财政年份:2021
- 资助金额:
$ 34.5万 - 项目类别:
Distal mRNA localization and translation in neural stem cells of the developing brain
发育中大脑的神经干细胞中的远端 mRNA 定位和翻译
- 批准号:
10188661 - 财政年份:2018
- 资助金额:
$ 34.5万 - 项目类别:
Distal mRNA localization and translation in neural stem cells of the developing brain
发育中大脑的神经干细胞中的远端 mRNA 定位和翻译
- 批准号:
10435490 - 财政年份:2018
- 资助金额:
$ 34.5万 - 项目类别:
Post-transcriptional RNA regulation in mammalian neural stem cells
哺乳动物神经干细胞的转录后RNA调控
- 批准号:
9317830 - 财政年份:2017
- 资助金额:
$ 34.5万 - 项目类别:
Mechanisms of neural progenitor division in the developing brain
大脑发育中神经祖细胞分裂的机制
- 批准号:
8665501 - 财政年份:2013
- 资助金额:
$ 34.5万 - 项目类别:
Essential requirements of Eif4a3 in brain development and disease
Eif4a3 在大脑发育和疾病中的基本需求
- 批准号:
10415906 - 财政年份:2013
- 资助金额:
$ 34.5万 - 项目类别:
Essential requirements of Eif4a3 in brain development and disease
Eif4a3 在大脑发育和疾病中的基本需求
- 批准号:
10178122 - 财政年份:2013
- 资助金额:
$ 34.5万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 34.5万 - 项目类别:
Next Generation Opto-GPCRs for Neuromodulatory Control
用于神经调节控制的下一代 Opto-GPCR
- 批准号:
10515612 - 财政年份:2023
- 资助金额:
$ 34.5万 - 项目类别:
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics
开发自噬靶向嵌合体并优化大分子治疗的细胞渗透
- 批准号:
10558145 - 财政年份:2023
- 资助金额:
$ 34.5万 - 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
- 批准号:
10735151 - 财政年份:2023
- 资助金额:
$ 34.5万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 34.5万 - 项目类别: